582 related articles for article (PubMed ID: 18597957)
1. Are pharmaceutics really going supercritical?
Pasquali I; Bettini R
Int J Pharm; 2008 Dec; 364(2):176-87. PubMed ID: 18597957
[TBL] [Abstract][Full Text] [Related]
2. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.
Pasquali I; Bettini R; Giordano F
Adv Drug Deliv Rev; 2008 Feb; 60(3):399-410. PubMed ID: 17964684
[TBL] [Abstract][Full Text] [Related]
3. Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation.
Moribe K; Tozuka Y; Yamamoto K
Adv Drug Deliv Rev; 2008 Feb; 60(3):328-38. PubMed ID: 18006109
[TBL] [Abstract][Full Text] [Related]
4. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
Yasuji T; Takeuchi H; Kawashima Y
Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
[TBL] [Abstract][Full Text] [Related]
5. Separation processes for organic molecules using SCF Technologies.
Daintree LS; Kordikowski A; York P
Adv Drug Deliv Rev; 2008 Feb; 60(3):351-72. PubMed ID: 18006179
[TBL] [Abstract][Full Text] [Related]
6. Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics.
Pasquali I; Bettini R; Giordano F
Eur J Pharm Sci; 2006 Mar; 27(4):299-310. PubMed ID: 16388936
[TBL] [Abstract][Full Text] [Related]
7. Supercritical fluid technology: a promising approach in pharmaceutical research.
Girotra P; Singh SK; Nagpal K
Pharm Dev Technol; 2013 Feb; 18(1):22-38. PubMed ID: 23036159
[TBL] [Abstract][Full Text] [Related]
8. Validation of direct assay of an aqueous formulation of a drug compound AZY by chiral supercritical fluid chromatography (SFC).
Mukherjee PS
J Pharm Biomed Anal; 2007 Jan; 43(2):464-70. PubMed ID: 16930907
[TBL] [Abstract][Full Text] [Related]
9. [Pharmaceutical applications of supercritical carbon dioxide].
Delattre L
Ann Pharm Fr; 2007 Jan; 65(1):58-67. PubMed ID: 17299352
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of flash supercritical fluid chromatography and alternate sample loading techniques for pharmaceutical medicinal chemistry purifications.
Miller L; Mahoney M
J Chromatogr A; 2012 Aug; 1250():264-73. PubMed ID: 22771260
[TBL] [Abstract][Full Text] [Related]
11. Design and process aspects of laboratory scale SCF particle formation systems.
Vemavarapu C; Mollan MJ; Lodaya M; Needham TE
Int J Pharm; 2005 Mar; 292(1-2):1-16. PubMed ID: 15725549
[TBL] [Abstract][Full Text] [Related]
12. Micronization processes with supercritical fluids: fundamentals and mechanisms.
Martín A; Cocero MJ
Adv Drug Deliv Rev; 2008 Feb; 60(3):339-50. PubMed ID: 17996325
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles synthesis using supercritical fluid technology - towards biomedical applications.
Byrappa K; Ohara S; Adschiri T
Adv Drug Deliv Rev; 2008 Feb; 60(3):299-327. PubMed ID: 18192071
[TBL] [Abstract][Full Text] [Related]
14. Hot-melt extrusion--basic principles and pharmaceutical applications.
Lang B; McGinity JW; Williams RO
Drug Dev Ind Pharm; 2014 Sep; 40(9):1133-55. PubMed ID: 24520867
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrins as pharmaceutical solubilizers.
Brewster ME; Loftsson T
Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
[TBL] [Abstract][Full Text] [Related]
16. Purification method development for chiral separation in supercritical fluid chromatography with the solubilities in supercritical fluid chromatographic mobile phases.
Gahm KH; Tan H; Liu J; Barnhart W; Eschelbach J; Notari S; Thomas S; Semin D; Cheetham J
J Pharm Biomed Anal; 2008 Apr; 46(5):831-8. PubMed ID: 17531426
[TBL] [Abstract][Full Text] [Related]
17. Chiral separations in sub- and supercritical fluid chromatography.
Mangelings D; Vander Heyden Y
J Sep Sci; 2008 May; 31(8):1252-73. PubMed ID: 18401860
[TBL] [Abstract][Full Text] [Related]
18. Supercritical fluid chromatography for the enantioseparation of pharmaceuticals.
De Klerck K; Mangelings D; Vander Heyden Y
J Pharm Biomed Anal; 2012 Oct; 69():77-92. PubMed ID: 22366324
[TBL] [Abstract][Full Text] [Related]
19. "Innovative processes for bio-pharmaceuticals and poorly water-soluble API".
Müller-Goymann C; Kwade A
Eur J Pharm Biopharm; 2018 May; 126():1. PubMed ID: 29474867
[No Abstract] [Full Text] [Related]
20. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles.
Perrut M; Jung J; Leboeuf F
Int J Pharm; 2005 Jan; 288(1):3-10. PubMed ID: 15607252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
